Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
| Embolization Coil Market to grow by USD 481.9 million from 2022 to 2027, Abbott Laboratories and Achieva Medical are among the key companies -Technavio | ||
| By: PR Newswire Association LLC. - 06 Feb 2024 | Back to overview list |
|
|
NEW YORK, Feb. 6, 2024 /PRNewswire/ -- The embolization coil market is estimated to grow by USD 481.9 million from 2022 to 2027 at a CAGR of 5.69% according to Technavio. The market is segmented by application (neurology, oncology, peripheral vascular disease, cardiology, and others), type (detachable coil and pushable coil), and geography (North America, Europe, Asia, and the Rest Of World (ROW)).
Abbott Laboratories - The company offers an embolization coil and related products such as Amplatzer Vascular Plug II. BALT Group - The company offers embolization coils such as OptiMAX. Boston Scientific Corp.- The company offers embolization coils such as Interlock and IDC Detachable Embolization Coils. The availability of favorable reimbursement coverage is a key factor driving growth. In developed regions like North America and Europe, reimbursement for embolization coils is influenced by public or private payment systems. Governments are promoting their use through initiatives and favorable policies. In the US, Medicare and Medicaid cover procedures under DRG and APC payments, while CPT codes reimburse physicians. Emerging countries like China and India are also adopting reimbursement policies, leading to increased demand for advanced embolization coils.
Drivers, Trends, and Challenges have an impact on dynamics and can impact businesses. Find some insights from a free sample report! Why Buy?
Grow your profit margin with Technavio- Buy the Report What are the key data covered in this Embolization Coil Market report?
Technavio's SUBSCRIPTION platform Embolization Coil Market: Overview Embolization coils are crucial medical devices used in interventional radiology and endovascular procedures for vascular embolization. These coils are designed to block blood flow in specific vessels, often used in the treatment of aneurysms and other vascular disorders. The procedure, known as coil embolization, is a minimally invasive technique that offers advantages over traditional surgical methods. Radiopaque coils enable visualization during medical imaging, aiding in precise placement and monitoring. This technology is a key component of interventional cardiology and neurointerventional radiology, contributing to advancements in medical imaging and healthcare innovation. Embolization coils are part of a range of therapeutic devices used in arterial embolization, providing effective treatment options for various medical interventions in vascular medicine. Related Reports The Neuroendovascular Non-coils Market size is estimated to grow by USD 329.15 million at a CAGR of 4.29% between 2023 and 2028. The global flow diversion aneurysm treatment market size is estimated to grow by USD 2,107.08 million at a CAGR of 8.8% between 2022 and 2027. ToC: Executive Summary Market Landscape Market Sizing Historic Sizes Five Forces Analysis Segmentation by Application Segmentation by Type Segmentation by Geography Customer Landscape Geographic Landscape Drivers, Challenges, & Trends Company Landscape Company Analysis Appendix About Us Contact
SOURCE Technavio 
|
||
|
|
||
 | Back to overview list | |
View original content to download multimedia: